Healthtech Capital
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Healthtech Capital.
Key people at Healthtech Capital.
Key people at Healthtech Capital.
# HealthTech Capital: A Pioneering Force in Healthcare Innovation Investing
HealthTech Capital operates as a vertically-focused investment organization dedicated to funding and mentoring early-stage healthcare technology startups[1][2]. Founded in 2010, the organization pioneered a membership model that combines the strengths of angel investing, venture capital, and strategic mentorship within the healthcare sector[1]. The firm's mission centers on identifying promising digital health, medical device, pharmaceutical, and healthcare services companies at the intersection of healthcare with computer and mobility technologies[2][3].
The organization's investment philosophy emphasizes both financial returns and meaningful impact on healthcare delivery. Members explicitly view their participation as "a way to give back to the community, to help build successful HealthTech companies and to participate in the satisfaction that comes from changing healthcare delivery"[1]. This dual focus on profit and purpose has proven effective—HealthTech Capital's portfolio companies have collectively attracted over $1 billion in follow-on capital from leading venture and corporate investors[1].
HealthTech Capital was established in 2010 by Anne DeGheest, a healthcare executive and entrepreneur with over 35 years of experience in the life sciences sector[2]. DeGheest is recognized as a healthcare pioneer and thought leader who has built multiple unicorn companies throughout her career. Her track record is substantial: her life science portfolio companies have generated over $27 billion in market capitalization, including eight IPOs[2]. Beyond her entrepreneurial achievements, DeGheest has served as a CEO, VP, and board member for both public and private companies, bringing deep operational expertise to the organization she founded.
The organization emerged from DeGheest's recognition that early-stage healthcare technology companies needed more than capital—they required strategic mentorship, industry connections, and access to a network of experienced healthcare stakeholders. This insight led to the creation of a membership-based model that would eventually attract successful entrepreneurs, executives, clinicians, venture capitalists, and corporate investors[2].
HealthTech Capital combines the best features of angel groups and venture capital funds[3]. Rather than operating as a traditional VC fund with a fixed capital pool, the organization leverages a membership structure where accredited angel investors, healthcare systems, venture firms, and corporate investors collaborate on deal evaluation and portfolio support[1]. This approach provides startups with both capital and the collective wisdom of diverse healthcare stakeholders.
Unlike many investment organizations, HealthTech Capital offers customized mentoring programs to selected companies at no charge[2]. The organization provides strategic advice, industry connections, and business coaching to help startups navigate the complex healthcare landscape. Additionally, the firm operates an Analyst-in-Residence Program for post-graduate professionals passionate about healthcare technology, creating a pipeline of talent while supporting portfolio companies[2].
Though headquartered in Silicon Valley's Los Altos Hills, California, HealthTech Capital maintains a nationwide network of angel investors and has expanded internationally to include investors across Asia[2]. This geographic diversity allows the organization to identify opportunities across different markets while providing portfolio companies with geographically distributed expertise and potential customer connections.
The membership comprises all major healthcare stakeholders—providers, payers, and healthcare corporations—creating a unique ecosystem where portfolio companies gain access to potential customers, partners, and acquirers[2]. Corporate members are specifically interested in potential market collaborations, meaning portfolio companies often benefit from strategic partnerships beyond pure capital investment.
HealthTech Capital employs a structured monthly evaluation cycle where angel investors serve rotating terms on the Selection Committee[2]. The top companies are invited to present at monthly screening dinners, ensuring thorough due diligence and alignment with the organization's healthcare focus.
HealthTech Capital operates at a critical inflection point in healthcare technology adoption. The organization addresses a fundamental gap in the venture ecosystem: while general venture capital has become abundant, specialized expertise in healthcare technology remains scarce. Most traditional VCs lack deep clinical knowledge, regulatory understanding, and relationships with healthcare providers—precisely the assets HealthTech Capital's membership provides.
The timing of HealthTech Capital's model has proven prescient. Digital health adoption accelerated dramatically following the COVID-19 pandemic, and regulatory frameworks have become increasingly favorable to healthcare innovation. The organization's focus on mHealth, wearables, medical devices, diagnostics, and healthcare services positions it at the center of multiple high-growth market segments[4].
HealthTech Capital's influence extends beyond individual portfolio companies. By creating a structured ecosystem connecting investors, entrepreneurs, clinicians, and healthcare systems, the organization has helped legitimize healthcare technology as a distinct investment category. The organization's success—evidenced by over $1 billion in follow-on capital attracted by portfolio companies—has demonstrated that specialized, vertically-focused investing in healthcare can generate both financial returns and meaningful impact.
HealthTech Capital has established itself as a distinctive player in healthcare venture investing by solving a real problem: early-stage healthcare technology companies need more than capital; they need access to healthcare expertise, regulatory knowledge, and industry relationships. The organization's membership model, founder credibility, and track record of portfolio success position it well for continued influence.
Looking forward, several trends will likely shape HealthTech Capital's evolution. The consolidation of healthcare technology into larger platforms will create both challenges and opportunities—portfolio companies may face acquisition pressure, but successful exits will enhance the organization's reputation. Regulatory changes in digital health, AI in healthcare, and remote patient monitoring will create new investment opportunities aligned with the organization's expertise. Additionally, the organization's international expansion into Asia suggests recognition that healthcare innovation is increasingly global.
The fundamental thesis underlying HealthTech Capital remains compelling: healthcare represents one of the largest and most complex markets globally, yet it remains significantly underserved by technology innovation. An organization that can bridge the gap between technology entrepreneurs and healthcare stakeholders—providing both capital and strategic guidance—will continue to capture outsized returns while driving meaningful improvements in healthcare delivery. HealthTech Capital's 15-year track record suggests it has cracked this code.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2018 | Vuild | $920K Seed | — | Act One Ventures, Plug & Play Ventures, SOSV, Ulili, Visionaire Ventures, Marc Benioff |
| Aug 1, 2016 | Bloomlife | $6.0M Seed | — | Act One Ventures, Battery Ventures, CapitalG, Expa, Greylock, NEO, Next Play Ventures, Plug & Play Ventures, SOSV, Ulili, Visionaire Ventures, Y Combinator, Adrian Aoun, Charlie Songhurst, Drew Houston, Farzad Nazem, Gabriel Naouri, Hadi Partovi, Henry Kravis, Jeff Bezos, Jeffrey Wilke, Marc Benioff, Nicolas Berggruen, Noosheen Hashemi, Shane Neman, Tom Chapman |
| Aug 1, 2016 | Naked Biome | $6.0M Seed | — | Act One Ventures, Battery Ventures, Plug & Play Ventures, SOSV, Ulili, Visionaire Ventures, Marc Benioff |
